Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD
The investigational drug finerenone met its primary endpoint in FIDELIO-DKD of slowing progression of chronic kidney disease (CKD) in patients with type 2 diabetes and CKD, said Rajiv Agarwal, MD, MS, FASN, a professor of medicine at Indiana University School of Medicine and a staff physician at the Veterans Affairs Medical Center in Indianapolis, Indiana.
Watch video Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD online, duration hours minute second in high quality that is uploaded to the channel AJMCtv MJH 23 October 2020. Share the link to the video on social media so that your subscribers and friends will also watch this video. This video clip has been viewed 4,767 times and liked it 41 visitors.
